226 related articles for article (PubMed ID: 30647078)
21. Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort.
Thijssen S; Wildiers H; Punie K; Beuselinck B; Clement P; Remmerie C; Berteloot P; Han S; Van Nieuwenhuysen E; Van Gorp T; Vergote I; Smeets A; Nevelsteen I; Floris G; Weltens C; Menten J; Janssen H; Laenen A; Neven P
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1041-1048. PubMed ID: 33471187
[TBL] [Abstract][Full Text] [Related]
22. Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer.
Riemsma R; Forbes CA; Kessels A; Lykopoulos K; Amonkar MM; Rea DW; Kleijnen J
Breast Cancer Res Treat; 2010 Aug; 123(1):9-24. PubMed ID: 20535542
[TBL] [Abstract][Full Text] [Related]
23. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
24. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
[TBL] [Abstract][Full Text] [Related]
25. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP
Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840
[TBL] [Abstract][Full Text] [Related]
26. The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients.
Stamatovic L; Susnjar S; Gavrilovic D; Minic I; Ursulovic T; Dzodic R
J BUON; 2018; 23(5):1273-1280. PubMed ID: 30570847
[TBL] [Abstract][Full Text] [Related]
27. Surgical treatment of 70 patients with brain metastases from breast carcinoma.
Wroński M; Arbit E; McCormick B
Cancer; 1997 Nov; 80(9):1746-54. PubMed ID: 9351543
[TBL] [Abstract][Full Text] [Related]
28. A high level of estrogen-stimulated proteins selects breast cancer patients treated with adjuvant endocrine therapy with good prognosis.
L H Weischenfeldt K; Kirkegaard T; Rasmussen BB; Giobbie-Hurder A; Jensen MB; Ejlertsen B; Lykkesfeldt AE
Acta Oncol; 2017 Sep; 56(9):1161-1167. PubMed ID: 28488912
[TBL] [Abstract][Full Text] [Related]
29. Retrospective analysis of risk factors for central nervous system metastases in operable breast cancer: effects of biologic subtype and Ki67 overexpression on survival.
Ishihara M; Mukai H; Nagai S; Onozawa M; Nihei K; Shimada T; Wada N
Oncology; 2013; 84(3):135-40. PubMed ID: 23235554
[TBL] [Abstract][Full Text] [Related]
30. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
[TBL] [Abstract][Full Text] [Related]
31. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
[TBL] [Abstract][Full Text] [Related]
32. Hormone treatment without surgery for patients aged 75 years or older with operable breast cancer.
Wink CJ; Woensdregt K; Nieuwenhuijzen GA; van der Sangen MJ; Hutschemaekers S; Roukema JA; Tjan-Heijnen VC; Voogd AC
Ann Surg Oncol; 2012 Apr; 19(4):1185-91. PubMed ID: 22031063
[TBL] [Abstract][Full Text] [Related]
33. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
[TBL] [Abstract][Full Text] [Related]
34. Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes.
Esin E; Oksuzoglu B; Bilici A; Cicin I; Kostek O; Kaplan MA; Aksoy S; Aktas BY; Ozdemir O; Alacacioglu A; Cabuk D; Sumbul AT; Sakin A; Paydas S; Yetisir E; Er O; Korkmaz T; Yildirim N; Sakalar T; Demir H; Artac M; Karaagac M; Harputluoglu H; Bilen E; Erdur E; Degirmencioglu S; Aliyev A; Cil T; Olgun P; Basaran G; Gumusay O; Demir A; Tanrikulu E; Yumuk PF; Imamoglu I; Oyan B; Cetin B; Haksoyler V; Karadurmus N; Erturk I; Evrensel T; Yilmaz H; Beypinar I; Kocer M; Pilanci KN; Seker M; Urun Y; Yildirim N; Eren T; Demirci U;
Cancer Chemother Pharmacol; 2019 Jan; 83(1):131-143. PubMed ID: 30377778
[TBL] [Abstract][Full Text] [Related]
35. Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Biomarker Analysis.
Zhou Y; Simmons J; Jordan CD; Sonbol MB; Maihle N; Tang SC
Clin Breast Cancer; 2019 Oct; 19(5):354-362.e7. PubMed ID: 31262687
[TBL] [Abstract][Full Text] [Related]
36. Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression.
Balduzzi A; Bagnardi V; Rotmensz N; Dellapasqua S; Montagna E; Cardillo A; Viale G; Veronesi P; Intra M; Luini A; Pruneri G; Mastropasqua G; Goldhirsch A; Colleoni M
Clin Breast Cancer; 2014 Aug; 14(4):258-64. PubMed ID: 24325948
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors for stage IV hormone receptor-positive primary metastatic breast cancer.
Kawano A; Shimizu C; Hashimoto K; Kinoshita T; Tsuda H; Fujii H; Fujiwara Y
Breast Cancer; 2013 Apr; 20(2):145-51. PubMed ID: 22139727
[TBL] [Abstract][Full Text] [Related]
38. Extended survival in women with brain metastases from HER2 overexpressing breast cancer.
Church DN; Modgil R; Guglani S; Bahl A; Hopkins K; Braybrooke JP; Blair P; Price CG
Am J Clin Oncol; 2008 Jun; 31(3):250-4. PubMed ID: 18525303
[TBL] [Abstract][Full Text] [Related]
39. Analysis of breast cancer survival in a northeastern Brazilian state based on prognostic factors: A retrospective cohort study.
Marques AD; Moura AR; Hora EC; Brito ÉAC; Oliviera LS; Feitosa IR; Freitas FF; Lima MS; de Carvalho Barreto ÍD; Santos MO; da Silva AM; Lima CA
PLoS One; 2022; 17(2):e0263222. PubMed ID: 35113931
[TBL] [Abstract][Full Text] [Related]
40. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
Berry J
Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
